State of the art review on #advancedHF, including #classification, indications for #circulatorysupport / #VAD, #transplant @JACCJournals #HeartFailure #HF #HFrEF #HFpEF https://t.co/Y7X5rIuIMS

11) Hypotension is a major limiting factor for pharmacological therapy especially in #HFrEF. #AHA/#ACC/#HFSA include hypotension in the criteria for #AdvancedHF. New therapies with low or no impact in ⬇️#bloodpressure in this population are a major change for these patients.

A few more slides on #advancedHF @rachkataria Full house in the fellows’ lounge to catch this talk. The #PowerOfZoom!! @laura_goodliffe

Delighted to host @rachkataria for #ClinicianRounds at #McMaster. She gave us a superb, practical case-based approach to management of #advancedHF and referral to #cardiactransplant

📌Patients with #advancedHF➡️ OMT are limited by symptomatic hypotension, resulting in ⬆️ risk of MACE 📌Subanalyses of GALACTIC-HF, suggest omecamtiv mecarbil benefit in advanced disease (NYHA III/IV, LVEF ≤30%, recent HFH) and now also in patients with lower SBP

When & why to refer to an #advancedHF centre? 🫀 Perfectly summarized by @GuiBaudry: ⚠️Early recognition: assess 5 high-risk situations: 🔹Ambulatory worsening HF 🔹Hospitalized HF 🔹Low cardiac output syndrome 🔹Cardiogenic shock 🔹Electrical storm ⚠️Timely referral: 🔹Use

34) #Vericiguat showed in #VICTORIA that can change the trajectory of #HFrEF pts if started after a 1st #WorseningHF event preventing further episodes of hospitalization or further worsening and progression to #AdvancedHF.

Some of our amazing advanced heart failure staff. It's a great experience to rotate and learn from them! #advancedHF #CardioTwitter

#AdvancedHF management: #LVAD 🆚 #HeartTx: Not one-size-fits-all Presented by none other than @heartofthemater 🫀 📍Both are excellent options for selected pts 📍Decision-making is complex → not simple guidelines 📍 In today’s era of stronger LVAD outcomes, choice should be

The novel criteria of #AdvancedHF by #HFA in this issue of EJHF. They are combined with a beautiful editorial on “Transatlantic Perspectives on the new criteria” What’s your view @ShelleyZieroth @DrNancySweitzer? @ESC_Journals @MarcoMetra @MihaiTrofenciuc @lamcardio

We are excited to welcome our new Faculty @valeriaduarteMD & Rayan Yousefzai @HMethodistCV -emerging leaders in #ACHD (Valeria) from Boston Children/MGH and #advancedHF (Rayan) from Brown/Tufts Program. A pleasure to have this amazing couple among us. @ACCinTouch @HFSA @SCMRorg

Yesterday got the pleasure to do #CVICU #AdvancedHF rounds with one of my #LifeMentor @JenCookMD 🫀#ProtectMyHfromF #StaySafeQD #cardiotwitter

Inotropes may improve functional status, but no impact on survival in #advancedHF. Evidence needed for #palliativeinotropes. @ShannonMDunlay Commentary by Dr. Carl Leier #JACCHF https://t.co/yg56NqjkXv

@MinnowWalsh on #SexDifferences in #AdvancedHF 📍#MCS w/ CF #LVAD - underused in F - associated with ⬆️mortality & ⬇️heart #transplantation in F relative to matched M comparators 📍Among adults listed for cardiac transplantation, vast majority are M @ersied727 @HeartOTXHeartMD

What if optimizing #GDMT is no longer possible❓ This often signals that the patient has entered #advancedHF, making it crucial to recognize when to refer them for advanced therapies or #palliative care. ⚠️ Dr #MariaLeiro pointed that: 🔑 The key is identifying that golden

How many have you read this novel criteria of #AdvancedHF by #HFA in this issue of EJHF. https://t.co/124mWoTOUZ

Introduction to heart transplant lecture by our advanced heart failure fellow, Dr. Krystof Andres. #HeartFailure #hearttransplant #advancedHF

To keep up the (hard) heart work... Patient out of the woods now but still impressive how low it gets. #cardiotwitter #advancedHF #CardiogenicShock

#GALACTIC_HF Pts with #AdvancedHF identified by: 🧩 ⬇️ LVEF 🧩 NYHA III-IV 🧩 Higher NT-proBNP 🧩⬇️ Median SBP Are those who benefit most from #OmecamtivMecarbil @Cytokinetics @NEJM @JJheart_doc @gcfmd @ValleAlfonso @FrancescoPaneni @DBelardoMD @HeartOTXHeartMD @gbiondizoccai